Tularik Inc. (TLRK) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Tularik Inc. (TLRK)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (223)	6/13/2002 6:11:27 PM
From: keokalani'nui	Read Replies (2) of 598

The gs tlrk presentation was not convincing on T67, but the peek at the preclinical candidates showed enormous potential value. They will need P3 in HCC to carry them to the financing/valuation event, but I am pretty sure now it will be what (lipid/HDL, Obesity, insulin sensitizer) enters the clinic in the next 12 months that will sell the stock. I am averaging down. Sorry Rick, I haven't been picking them too well lately. Wilder

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next